Skip to main content
. 2022 Mar 22;14(1):2050636. doi: 10.1080/19490976.2022.2050636

Table 1.

Patient baseline demographics

Demographics mean (SD) or n (%) Non-operative controls n = 25 Sleeve gastrectomy n = 18 Roux-en-Y gastric bypass n = 27 p-value
Number of patients (n) 25 18 27 -
Age at surgery (years) 47.7 (8.7) 47.9 (9.7) 47 (9.9) 0.940
Sex (female) 20 (80.0%) 17 (94.4%) 25 (92.6%) 0.356
Height (m) 1.67 (0.07) 1.69 (0.07) 1.67 (0.08) 0.725
Body mass index (kg/m2) 47.1 (7.3) 40.8 (5.7) 42.9 (4.2) 0.002
General anxiety disorder 7 (28.0) 10 (55.6) 11 (40.7) 0.194
Coronary artery disease 0 (0.0) 0 (0.0) 0 (0.0) 1.000
Depression 13 (52.0) 10 (55.6) 15 (55.6) 0.982
Type 2 diabetes 2 (8.0) 1 (5.6) 3 (11.1) 0.877
Dyslipidemia 8 (32.0) 8 (44.4) 6 (22.2) 0.301
Gastroesophageal reflux 8 (32.0) 8 (44.4) 13 (48.2) 0.505
Hypertension 8 (32.0) 6 (33.3) 10 (37.0) 0.949
Hypothyroidism 4 (16.0) 5 (27.8) 6 (22.2) 0.661
Fatty liver disease 4 (16.0) 5 (27.8) 5 (18.5) 0.649
Osteoarthritis 12 (48.0) 9 (50.0) 9 (33.3) 0.444
Polycystic ovarian syndrome 1 (4.0) 3 (16.7) 2 (7.4) 0.428
Asthma 4 (16.0) 2 (11.1) 5 (18.5) 0.916
Obstructive sleep apnea 11 (44.0) 10 (55.6) 15 (55.6) 0.718
Ex-smoker 8 (32.0) 1 (5.6) 6 (22.2) 0.120
EOSS
0
1
2
3
0 (0.0)
2 (8.0)
21 (84.0)
2 (8.0)
0 (0.0)
1 (5.6)
16 (88.9)
1 (5.6)
3 (11.1)
3 (11.1)
20 (74.1)
1 (3.7)
0.625

EOSS, Edmonton obesity staging system.